Form 8-K/A Alexza Pharmaceuticals For: Mar 21
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Alexza Pharma (ALXA) Reports Q4 Loss of $0.15/Share; Warns it May Shut Down
March 28, 2016 4:12 PM EDTAlexza Pharma (NASDAQ: ALXA) reported Q4 EPS of ($0.15), versus ($0.35) reported last year. Revenue for the quarter came in at $673 thousand, versus $1.45 million reported last year.
Alexza believes that, based on its cash and cash equivalent balances at December 31, 2015, the additional $1.0 million drawn... More
